Laura Melado Vidales: Integrating High-Specific Assays for Anti-Müllerian Hormone with Antral Follicle Count
Laura Melado Vidales, Medical Director at ART Fertility Clinics Abu Dhabi, shared a post on LinkedIn about a paper published in Frontiers:
“Excited to share that our new paper is out in Frontiers in Endocrinology!
‘How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-Müllerian hormone with antral follicle count.’
Read here.
We show that combining high-specific AMH assays with antral follicle count (AFC) improves the prediction of ovarian response in women with low ovarian reserve, supporting more personalized fertility care.
Grateful to my co-authors and colleagues for this great collaboration!”
Title: How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count
Authors: Laura Melado, Ajay Kumar, Bhanu Kalra, Erkan Kalafat, Barbara Lawrenz, Human Fatemi
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 21, 2025, 06:53New Guidelines on Frozen Embryo Transfer Released – RBMO
-
Dec 21, 2025, 06:32What is JAMA+ Women’s Health? – JAMA+ Women’s Health
-
Dec 21, 2025, 06:20Contraceptive Use and Ovarian Reserve Interactions – Fertility and Sterility
-
Dec 21, 2025, 02:55Epigenetic Links Between Paternal Age, Reproduction and Offspring Health – Reproduction and Fertility
-
Dec 21, 2025, 02:43Medicines and Pregnancy: ANSM Proposes New Labeling – B’RIGHT
-
Dec 21, 2025, 02:28Steven Palter: It is time to retire the out of date ‘2 week wait’ for pregnancy tests after IVF
-
Dec 21, 2025, 02:24Thorsten Waloschek: New Study Highlights Preeclampsia Risk Stratification Benefits
-
Dec 21, 2025, 02:15Siddhartha Yadav: New ASCO Guideline for Managing Cancer During Pregnancy
-
Dec 21, 2025, 01:56New Patient Resource on Thyroid Issues in Pregnancy – RCOG